Locus specific human endogenous retroviruses reveal new lymphoma subtypes.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
08 Jun 2023
Historique:
pubmed: 19 6 2023
medline: 19 6 2023
entrez: 19 6 2023
Statut: epublish

Résumé

The heterogeneity of cancers are driven by diverse mechanisms underlying oncogenesis such as differential 'cell-of-origin' (COO) progenitors, mutagenesis, and viral infections. Classification of B-cell lymphomas have been defined by considering these characteristics. However, the expression and contribution of transposable elements (TEs) to B cell lymphoma oncogenesis or classification have been overlooked. We hypothesized that incorporating TE signatures would increase the resolution of B-cell identity during healthy and malignant conditions. Here, we present the first comprehensive, locus-specific characterization of TE expression in benign germinal center (GC) B-cells, diffuse large B-cell lymphoma (DLBCL), Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt lymphoma (BL), and follicular lymphoma (FL). Our findings demonstrate unique human endogenous retrovirus (HERV) signatures in the GC and lymphoma subtypes whose activity can be used in combination with gene expression to define B-cell lineage in lymphoid malignancies, highlighting the potential of retrotranscriptomic analyses as a tool in lymphoma classification, diagnosis, and the identification of novel treatment groups.

Identifiants

pubmed: 37333202
doi: 10.1101/2023.06.08.544208
pmc: PMC10274920
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R01 CA260691
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007739
Pays : United States

Déclaration de conflit d'intérêts

Declaration of Interests Peter Martin: ADCT: Consultancy. All other authors declare no competing interests.

Auteurs

Bhavya Singh (B)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Nicholas Dopkins (N)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Tongyi Fei (T)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Jez L Marston (JL)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Stephanie Michael (S)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Helena Reyes-Gopar (H)

Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Departamento de Genómica Computacional, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.

Gislaine Curty (G)

Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Jonas J Heymann (JJ)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Amy Chadburn (A)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Peter Martin (P)

Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

Fabio E Leal (FE)

Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Ethel Cesarman (E)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Douglas F Nixon (DF)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Matthew L Bendall (ML)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Classifications MeSH